| abstract |
Compounds having the structure of formula (I) are provided: or a pharmaceutically acceptable salt, homolog, hydrate or solvate thereof, wherein Ra is as defined herein. Such compounds are useful as modulators of the sphingosine-1-phosphate receptor and have utility in the treatment of diseases in which activation of this receptor is medically indicated. |